Revolution Medicines' pancreatic cancer drug daraxonrasib succeeds in trial
Medicines of the revolution'The pancreatic cancer drug was successful in a highly anticipated Phase 3 trial, nearly doubling the typical…
Goldsmith Marks
Ben Sasse highlights daraxonrasib for pancreatic cancer
Medicines of the revolution could be on the cusp of a breakthrough. The company hopes to soon publish results from…